Carregant...
Ageing is a risk factor in imatinib mesylate cardiotoxicity
AIMS: Chemotherapy-induced heart failure is increasingly recognized as a major clinical challenge. Cardiotoxicity of imatinib mesylate, a highly selective and effective anticancer drug belonging to the new class of tyrosine kinase inhibitors, is being reported in patients, some progressing to conges...
Guardat en:
| Publicat a: | Eur J Heart Fail |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4238824/ https://ncbi.nlm.nih.gov/pubmed/24504921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.58 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|